Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.
Houdini Bio has raised $1.9M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2026.
Houdini Bio's investors include SCVC, University of Cambridge, Deep Science Ventures.
Houdini Bio is headquartered in London, United Kingdom.
Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.
Houdini Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Houdini Bio — Funding & Investors." VCBacked, June 19, 2026, https://www.vcbacked.co/company/houdini-bio. Accessed September 30, 2026.
VCBacked. (2026). Houdini Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/houdini-bio
{{cite web |title=Houdini Bio — Funding & Investors |url=https://www.vcbacked.co/company/houdini-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated